Shopping Cart
- Remove All
Your shopping cart is currently empty
DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM. DK419 decreases protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 and Survivin.It also induces production of pAMPK.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $79 | In Stock | |
| 5 mg | $173 | In Stock | |
| 10 mg | $273 | In Stock | |
| 25 mg | $451 | In Stock | |
| 50 mg | $636 | In Stock | |
| 100 mg | $858 | In Stock |
| Description | DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM. DK419 decreases protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 and Survivin.It also induces production of pAMPK. |
| In vitro | DK419 inhibited the growth of CRC tumor cells in vitro and had good plasma exposure when dosed orally[1]. |
| In vivo | DK419 inhibited the growth of patient derived CRC240 tumor explants in mice dosed orally[1]. |
| Molecular Weight | 407.7 |
| Formula | C16H8ClF6N3O |
| Cas No. | 2102672-22-8 |
| Smiles | FC(F)(F)c1nc2cc(Cl)cc(C(=O)Nc3ccc(cc3)C(F)(F)F)c2[nH]1 |
| Relative Density. | 1.611 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL (insoluble or slightly soluble), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.